What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In the United States, $50,000 per Quality-Adjusted Life-Year (QALY) is a decision rule that is often used to guide interpretation of cost-effectiveness analyses. However, many investigators have questioned the scientific basis of this rule, and it has not been updated. METHODS: We used 2 separate approaches to investigate whether the $50,000 per QALY rule is consistent with current resource allocation decisions. To infer a lower bound for the decision rule, we estimated the incremental cost-effectiveness of recent (2003) versus pre-"modern era" (1950) medical care in the United States. To infer an upper bound for the decision rule, we estimated the incremental cost-effectiveness of unsubsidized health insurance versus self-pay for nonelderly adults (ages 21-64) without health insurance. We discounted both costs and benefits, following recommendations of the Panel on Cost-Effectiveness in Health and Medicine. RESULTS: Our base case analyses suggest that plausible lower and upper bounds for a cost-effectiveness decision rule are $183,000 per life-year and $264,000 per life-year, respectively. Our sensitivity analyses widen the plausible range (between $95,000 per life-year saved and $264,000 per life-year saved when we considered only health care's impact on quantity of life, and between $109,000 per QALY saved and $297,000 per QALY saved when we considered health care's impact on quality as well as quantity of life) but it remained substantially higher than $50,000 per QALY. CONCLUSIONS: It is very unlikely that $50,000 per QALY is consistent with societal preferences in the United States.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Others have estimated a range of approximately $100,000-$300,000 based on trends in healthcare spending and population health gains (Braithwaite, Meltzer, King, Leslie, & Roberts, 2008).”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Braithwaite, Meltzer, King, Leslie, & Roberts, 2008
Citations
Cites
Cost-Effectiveness in Health and Medicine
(1996) · doi:10.1093/oso/9780195108248.001.0001 · Cited by 7,193
Free for All? Lessons from the RAND Health Insurance Experiment
Neuberg, L. G., Newhouse, J. P., & Group, I. E. (1995) · Southern Economic Journal · doi:10.2307/1061020 · Cited by 991
Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard
Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, A. M., & Weissert, W. G. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000310 · Cited by 850 · cited 2×
“Nonetheless, this limitation should be interpreted in the context of the limitations of prior studies (eg, inferring WTP for health care from driving behavior by comparing speeding-related time savings with speeding-related health risks).(6) These studies not only had similar limitations regarding the accuracy of expe…”
BackgroundEichler, H.-G., Kong, S. X., Gerth, W. C., Mavros, P., & Jönsson, B. (2004) · Value in Health · doi:10.1111/j.1524-4733.2004.75003.x · Cited by 788 · cited 2×
“Investigators have long called for additional research to improve the methodological bases of decision rules.(9,10) However, published reports have had significant limitations, asking individuals about their willingness to pay for hypothetical health purchases (in which case people may be far more willing to spend hyp…”
BackgroundThe Beaver Dam Health Outcomes study: Initial Catalog of Health-state Quality Factors
Fryback, D. G., Dasbach, E. J., Klein, R., Klein, B. E. K., Dorn, N., Peterson, K., & Martin, P. A. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300202 · Cited by 733 · cited 1×
“Accordingly, we performed sensitivity analyses to estimate QALYs attributable to modern health care both with a pessimistic assumption (health care confers no qualityimprovement aside from mortality reduction, in which case people often purchase “quality-impaired” years) as well as with an optimistic assumption (healt…”
MethodWhat Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation?
Ubel, P. A., Hirth, R. A., Chernew, M. E., & Fendrick, A. M. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1637 · Cited by 588 · cited 2×
“Our sensitivity analyses widen the plausible range (between $95,000 per life-year saved and $264,000 per life-year saved when we considered only health care’s impact on quantity of life, and between $109,000 per QALY saved and $297,000 per QALY saved when we considered health care’s impact on quality as well as quanti…”
BackgroundFree for all?: lessons from the Rand Health Insurance Experiment
(1994) · Choice Reviews Online · doi:10.5860/choice.32-0341 · Cited by 584
Development of WHO guidelines on generalized cost-effectiveness analysis
Murray, C. J. L., Evans, D. B., Acharya, A., & Baltussen, R. M. P. M. (2000) · Health Economics · doi:10.1002/(sici)1099-1050(200004)9:3<235::aid-hec502>3.0.co;2-o · Cited by 577
The Value of Medical Spending in the United States, 1960–2000
Cutler, D. M., Rosen, A. B., & Vijan, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa054744 · Cited by 446
Health Insurance and Mortality: Evidence From a National Cohort
Franks, P. (1993) · JAMA · doi:10.1001/jama.1993.03510060083037 · Cited by 328 · cited 1×
“The resulting impact (17% reduction in probability of death) was broadly consistent with the observational analysis (25% mortality reduction) cited by the Institute of Medicine’s report on the impact of uninsurance.(34,35)”
ResultImproving Health: Measuring Effects of Medical Care
Bunker, J. P., Frazier, H. S., & Mosteller, F. (1994) · The Milbank Quarterly · doi:10.2307/3350295 · Cited by 315
Piette, J. D., Wagner, T. H., Potter, M. B., & Schillinger, D. (2004) · Medical Care · doi:10.1097/01.mlr.0000108742.26446.17 · Cited by 293
The role of medical care in contributing to health improvements within societies
Bunker, J. P. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.6.1260 · Cited by 269
Effects of health insurance and race on colorectal cancer treatments and outcomes
(2000) · American Journal of Public Health · doi:10.2105/ajph.90.11.1746 · Cited by 258
Free for All? Lessons from the RAND Health Insurance Experiment
(1993) · Harvard University Press eBooks · doi:10.7249/cb199 · Cited by 247
The demand for episodes of treatment in the health insurance experiment
Keeler, E. B., & Rolph, J. E. (1988) · Journal of Health Economics · doi:10.1016/0167-6296(88)90020-3 · Cited by 224 · cited 1×
“31.(31) Individuals with health insurance pay 18% of full TABLE 1.”
BackgroundKing, J. T., Tsevat, J., Lave, J. R., & Roberts, M. S. (2005) · Medical Decision Making · doi:10.1177/0272989x05282640 · Cited by 219 · cited 1×
“Our results contrast with a recent study that has used contingent valuation to query individuals’ hypothetical WTP to obtain perfect health, which estimated WTP per QALY well below $50,000.(42) However, this study placed a cap on the ratio of expenditures to annual income, and assumed that expenditures must occur at o…”
ResultSelf-citationNeumann, P. J., Sandberg, E. A., Bell, C. M., Stone, P. W., & Chapman, R. H. (2000) · Health Affairs · doi:10.1377/hlthaff.19.2.92 · Cited by 180
Haas, J. S., & Goldman, L. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.10.1605 · Cited by 169
Trends In Medical Spending By Age, 1963–2000
Meara, E., White, C., & Cutler, D. M. (2004) · Health Affairs · doi:10.1377/hlthaff.23.4.176 · Cited by 169 · cited 1×
“Health care was assumed to induce age-stratified costs based on the analysis of data by Meara et al from the 2000 Medical Expenditure Panel Survey (N 34,459) (Table 2).(21) Although there are no published data on 1950 medical costs that are stratified by age, we do know that per-capita spending on health was 13% of cu…”
MethodEditorial: Some reflections on cost-effectiveness analysis
Johannesson, M., & Meltzer, D. O. (1998) · Health Economics · doi:10.1002/(sici)1099-1050(199802)7:1<1::aid-hec327>3.0.co;2-u · Cited by 167
Self-citationMathematical programming for the efficient allocation of health care resources
Stinnett, A. A., & Paltiel, A. D. (1996) · Journal of Health Economics · doi:10.1016/s0167-6296(96)00493-6 · Cited by 163
The contribution of medical care to mortality decline: McKeown revisited
Mackenbach, J. P. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00200-4 · Cited by 137
Payer Status and the Utilization of Hospital Resources in Acute Myocardial Infarction
Canto, J. G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.817 · Cited by 112
The value of medical spending in the United States.
Braithwaite, R. S., & Roberts, M. S. (2006) · PubMed · Cited by 110
Self-citationBunker, J. P. (1995) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)00625-7 · Cited by 95
Goossens, M. E. J. B., Rutten-Van Mölken, M. P. M. H., Kole-Snijders, A. M. J., Vlaeyen, J. W. S., Van Breukelen, G., & Leidl, R. (1998) · Health Economics · doi:10.1002/(sici)1099-1050(199802)7:1<39::aid-hec323>3.0.co;2-s · Cited by 94
Self-citationTengs, T. O. (2004) · Value in Health · doi:10.1111/j.1524-4733.2004.71246.x · Cited by 85
Inequities in hospital care, the Massachusetts experience.
Young, G. J., & Cohen, B. B. (1991) · PubMed · Cited by 62
Americans' Views of Health Care Costs, Access, and Quality
Blendon, R. J., Brodie, M., Benson, J. M., Altman, D. E., & Buhr, T. (2006) · Milbank Quarterly · doi:10.1111/j.1468-0009.2006.00463.x · Cited by 60 · cited 1×
“A majority of Americans have consistently believed that the United States is spending too little rather than too much on health care.(11) In the 2006 General Social Survey,(12) a sample of 2992 adults living in households in the United States, 74% thought we were spending “too little” on health care, 19% thought spend…”
BackgroundThe Value of Medical Spending in the United States
Barr, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmc062711 · Cited by 37 · cited 1×
“Additionally, their estimated cost-effectiveness also was broadly consistent with our result when the same discounting assumptions were made (approximately $20,000 per LY saved, Cutler et al; approximately $28,000 per LY saved, current study, discounting costs and but not discounting benefits).(41) However, because co…”
ResultThresholds in Cost-Effectiveness Analysis—More of the Story
Laufer, F. N. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.08103.x · Cited by 21
Einstein on Willingness to Pay per QALY: Is There a Better Way?
Johnson, F. R. (2005) · Medical Decision Making · doi:10.1177/0272989x05283084 · Cited by 14
Polsky, D. E. (2005) · Medical Decision Making · doi:10.1177/0272989x05283136 · Cited by 13
Research works printed but not linked: 4
- Taylor, 2003, Why not spend more on health care?, Health Interactive Health Care News, 3, 12
- 2002, Life Expectancy by Age, Race, and Sex: Death Registration States, 1900–1902 to 1919–1921, and United States, 1929–1931 to 2000. Table 11. US Census Bureau., Natl Vital Stat Rep, 51, 29
- 2002, Life Table for the Total Population: United States, 2002. Table 1. US Census Bureau., Natl Vital Stat Rep, 53, 7
- Braithwaite, 2005, $50,000 per QALY: inertia, indifference, or irrationality?, Med Decis Making, 25, E1
Cited by
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold
Neumann, P. J., Cohen, J. T., & Weinstein, M. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1405158 · Cited by 2,249
Delivering affordable cancer care in high-income countries
Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N. J., Amir, E., Khayat, D., Boyle, P., Autier, P., Tannock, I. F., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70141-3 · Cited by 718
Self-citationAssessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
Grosse, S. D. (2008) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.8.2.165 · Cited by 637
Estimating the Economic Burden of Racial Health Inequalities in the United States
LaVeist, T. A., Gaskin, D., & Richard, P. (2011) · International Journal of Health Services · doi:10.2190/hs.41.2.c · Cited by 378
“Given that recent studies have valued a quality-adjusted life year at $95,000 to $264,000 (29), $50,000 is a conservative estimate.”
Background
Metadata
- Authors
- Braithwaite, R. S., Meltzer, D. O., King, J. T., Leslie, D., & Roberts, M. S.
- Affiliations
- Yale University (US)
- University of Chicago (US)
- United States Department of Veterans Affairs (US)
- University of Pittsburgh (US)
- Corresponding author
- Braithwaite, R Scott
- Venue
- Medical Care
- Published
- 2008-04
- Volume
- 46
- Issue
- 4
- Pages
- 349-356
- ISSN
- 0025-7079 (ISSN-L)
- OpenAlex
- W2134047636
- Cited by
- 579
- References
- 33
- Citations by year
- 2026: 1 · 2025: 18 · 2024: 12 · 2023: 15 · 2022: 22 · 2021: 23 · 2020: 26 · 2019: 36 · 2018: 31 · 2017: 50 · 2016: 43 · 2015: 48 · 2014: 49 · 2013: 47 · 2012: 45
- FWCI
- 85.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medical Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- quality-adjusted life years, cost-effectiveness threshold, resource allocation, incremental cost-effectiveness, uninsured adults, health insurance, health care spending, societal preferences, discounting
- MeSH terms
- Adult, Cost-Benefit Analysis, Decision Support Techniques, Female, Health Policy, Humans, Insurance, Health, Life Expectancy, Male, Middle Aged, Reference Values, Time Factors, United States, Health Care Rationing, Age Distribution, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.